Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O95571: Variant p.Thr152Ile

Persulfide dioxygenase ETHE1, mitochondrial
Gene: ETHE1
Feedback?
Variant information Variant position: help 152 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Threonine (T) to Isoleucine (I) at position 152 (T152I, p.Thr152Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (T) to medium size and hydrophobic (I) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In EE; reduces protein stability, iron content and enzyme activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 152 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 254 The length of the canonical sequence.
Location on the sequence: help SPGHTPGCVTFVLNDHSMAF T GDALLIRGCGRTDFQQGCAK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         SPGHTPGCVTFVLNDHSMAFTGDALLIRGCGRTDFQQGCAK

Mouse                         SPGHTPGCVTFVLNDQSMAFTGDALLIRGCGRTDFQQGCAK

Bovine                        SPGHTPGCVTFVLNDHSMAFTGDALLIRGCGRTDFQQGCAE

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 8 – 254 Persulfide dioxygenase ETHE1, mitochondrial
Binding site 135 – 135
Binding site 154 – 154
Modified residue 172 – 172 N6-acetyllysine; alternate
Modified residue 172 – 172 N6-succinyllysine; alternate
Beta strand 147 – 153



Literature citations
Characterization of patient mutations in human persulfide dioxygenase (ETHE1) involved in H2S catabolism.
Kabil O.; Banerjee R.;
J. Biol. Chem. 287:44561-44567(2012)
Cited for: FUNCTION; CATALYTIC ACTIVITY; COFACTOR; BIOPHYSICOCHEMICAL PROPERTIES; SUBUNIT; ACTIVITY REGULATION; CHARACTERIZATION OF VARIANTS EE ILE-152 AND ASN-196; Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy.
Mineri R.; Rimoldi M.; Burlina A.B.; Koskull S.; Perletti C.; Heese B.; von Dobeln U.; Mereghetti P.; Di Meo I.; Invernizzi F.; Zeviani M.; Uziel G.; Tiranti V.;
J. Med. Genet. 45:473-478(2008)
Cited for: VARIANTS EE PRO-55; ALA-136; ILE-152; GLN-163; TRP-163; LYS-164; ARG-185 AND ASN-196; CHARACTERIZATION OF VARIANTS EE PRO-55 AND LYS-164;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.